We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current XGN market cap is 73.19M. The company's latest EPS is USD -1.3431 and P/E is -2.99.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 13.42M | 13.77M | 14.42M | 15.06M | 12.51M |
| Operating Income | -5.77M | -5.15M | -3M | -2.59M | -4.65M |
| Net Income | -5.42M | -5.57M | -3.36M | -2.97M | -5.02M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 40.39M | 41.98M | 48.3M | 45.56M | 52.55M |
| Operating Income | -9.3M | -15.19M | -24.07M | -46.05M | -22.84M |
| Net Income | -12.04M | -16.69M | -26.85M | -47.39M | -23.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 60.93M | 56.94M | 50.81M | 49.31M | 43.61M |
| Total Liabilities | 33.42M | 34.25M | 30.82M | 31.72M | 30.74M |
| Total Equity | 27.5M | 22.69M | 19.99M | 17.59M | 12.87M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 88.31M | 78.38M | 123.45M | 86.22M | 56.94M |
| Total Liabilities | 32.65M | 36.54M | 38.51M | 43.76M | 34.25M |
| Total Equity | 55.66M | 41.84M | 84.94M | 42.46M | 22.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.81M | -14.46M | -9.04M | -11.47M | -13.64M |
| Investing | -720k | -804k | -86k | -222k | -369k |
| Financing | -10.41M | -10.63M | -100k | -326k | -447k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.71M | -14.08M | -20.27M | -32.14M | -14.46M |
| Investing | -103k | -455k | -2.42M | -4.32M | -804k |
| Financing | 68.73M | -97k | 64.68M | -489k | -10.63M |
| Market Cap | 73.19M |
| Price to Earnings Ratio | -2.99 |
| Price to Sales Ratio | 1.35 |
| Price to Cash Ratio | 1.94 |
| Price to Book Ratio | 3.12 |
| Dividend Yield | - |
| Shares Outstanding | 17.64M |
| Average Volume (1 week) | 364.67k |
| Average Volume (1 Month) | 222.14k |
| 52 Week Change | 109.60% |
| 52 Week High | 6.22 |
| 52 Week Low | 1.3003 |
| Spread (Intraday) | 0.63 (15.18%) |
| Company Name | Exagen Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.exagen.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
